Back

Impact of VT pleomorphism on the prognostic value of non-inducibility after catheter ablation in patients with non-ischemic cardiomyopathy

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Catheter ablation of ventricular arrhythmias Ablation of Ventricular Arrhythmias ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Yoshitaka Kimura

Leiden University Medical Center, Leiden (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
First intention epicardial VT ablation: what are the results?
Doctor T. Graca Rodrigues (Lisbon, PT)
Abstract
Presentation thumbnail
Comparison of two methods to navigate the stereotactic body radiotherapy ablation for ventricular tachycardia, the invasive electrophysiological study and substrate identification
Doctor R. Neuwirth (Trinec, CZ)
Abstract Slides
Presentation thumbnail
Independent assessment if an image-processing service for the treatment of patients with ventricular tachycardias
Mr F. Spies (Basel, CH)
Abstract Slides
Presentation thumbnail
Catheter ablation of ventricular tachyarrhythmias in ischemic patients may contribute to better survival: a new clinical challenge
Doctor S. Garkina (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Critical sites for scar-related ventricular tachycardias treatment: an approach based on sinus rhythm late activation zones
Doctor A. Xavier Fontes (Ponta Delgada, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Catheter ablation of ventricular arrhythmias

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources